Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease
Journal of Clinical Oncology1999Vol. 17(4), pp. 1259–1259
Citations Over TimeTop 13% of 1999 papers
Kim E. Nichols, Seth Levitz, Kristen E. Shannon, Doke C.R. Wahrer, Daphne W. Bell, Gloria Chang, Sanjay R. Hegde, Donna Neuberg, Timothy D. Shafman, Nancy J. Tarbell, Peter Mauch, Chikashi Ishioka, Daniel A. Haber, Lisa Diller
Abstract
Analysis of the number of tumors per individual and the family history of cancer in our cohort suggests that genetic factors may contribute to development of secondary neoplasms in a subset of Hodgkin's disease survivors. Mutational analysis, however, does not support a significant role for heterozygous truncating ATM mutations. Future studies evaluating other genes involved in DNA damage response pathways are warranted.
Related Papers
- → Importance of family history and indications for genetic testing(2019)22 cited
- → Is a family history of coronary heart disease an independent coronary risk factor?(1985)27 cited
- → Impact of Colon Cancer Screening on Family History Phenotype(2012)7 cited
- → Family History of Cardiovascular Disease in Patients With Early Development of Acute Coronary Syndrome(2018)5 cited
- [Lp(a) and lipid order in a group of secondary school students selected according to their family anamnesis].(1994)